Orchestra BioMed Holdings Inc
Orchestra BioMed Holdings Inc (OBIO) Options Open Interest
OBIO options open interest is 2,445 contracts. The 2-week average daily volume is 60 contracts across the chain.
Read more
Monitoring OBIO open interest helps you see where real money is positioned on Orchestra BioMed Holdings Inc's options and which strikes are attracting the most commitment from traders. Orchestra BioMed Holdings Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor OBIO options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising OBIO options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Orchestra BioMed Holdings Inc to settle.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease.
Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where OBIO open interest is concentrated. Our scanner maps Orchestra BioMed Holdings Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Orchestra BioMed Holdings Inc's options open interest as the signal it is, not as an afterthought.
| 7.50 | — | 0.20 | 0.20 | 127% | +0.2364 | 422 |
| 5.00 | 0.60 | 1.45 | 1.03 | 91% | +0.8225 | 3 |
| 2.50 | 2.80 | 4.00 | 3.40 | 169% | +0.9936 | 0 |
| 10.00 | — | 0.75 | 0.75 | 333% | +0.3626 | 0 |
| 5.00 | — | 0.75 | 0.75 | 243% | -0.2818 | 1 |
| 7.50 | 1.20 | 2.15 | 1.68 | 93% | -0.8583 | 1 |
| 2.50 | — | 0.75 | 0.75 | 624% | -0.0947 | 0 |
| 10.00 | 3.40 | 4.60 | 4.00 | 32% | -1.0000 | 0 |
As of September 29, 2026
Follow the money
Track OBIO open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→